Skip to main content
Erschienen in: Infection 3/2014

01.06.2014 | Clinical and Epidemiological Study

Recurrent pneumococcal invasive disease in the Region of Madrid during a five-year period

verfasst von: J. C. Sanz, I. Rodríguez-Avial, E. Ríos, B. Ramos, E. Cercenado

Erschienen in: Infection | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to describe the clinical and microbiological characteristics of recurrent invasive pneumococcal disease (RIPD) cases identified in the Region of Madrid between January 2007 and December 2011.

Methods

Streptococcus pneumoniae serotyping was performed by Pneumotest-Latex and Quellung reaction. Molecular typing was carried out by pulsed-field gel electrophoresis (PFGE). A relapse was defined as any case of RIPD caused by strains with similar PFGE profile. Re-infections were defined by detection of recurrent episodes caused by strains with different PFGE patterns.

Results

During the study period, 2,929 S. pneumoniae strains isolated from 2,858 patients with invasive pneumococcal disease (IPD) were studied. In 61 patients (2.1 %), 132 episodes of RIPD were detected (two episodes in 52 patients, three in 8 and four in 1). Twelve patients had relapses, 47 had re-infections and two had re-infections followed by relapses. Common risk factors to developing RIPD were HIV (42.6 %) and haematological malignancies (16.4 %). The most frequent serotypes were 8 (16 episodes) and 19A (15 episodes). Fourteen strains that were resistant to levofloxacin were also resistant to erythromycin. The proportion of strains co-resistant to erythromycin and levofloxacin was significantly higher in relapses (11/29) than in re-infections (3/103).

Conclusions

The occurrence of repeated episodes of IPD in the same patient over the time is not an exceptional issue. Some underlying conditions that may favour these recurrences, mainly immunosuppression, need to be considered in patients having an episode of IPD.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Fenoll A, Granizo JJ, Aguilar L, Giménez MJ, Aragoneses-Fenoll L, Hanquet G, et al. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol. 2009;47:1012–20.PubMedCentralPubMedCrossRef Fenoll A, Granizo JJ, Aguilar L, Giménez MJ, Aragoneses-Fenoll L, Hanquet G, et al. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol. 2009;47:1012–20.PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Mufson MA, Hao JB, Stanek RJ, Norton NB. Clinical features of patients with recurrent invasive Streptococcus pneumoniae disease. Am J Med Sci. 2012;343:303–9.PubMedCrossRef Mufson MA, Hao JB, Stanek RJ, Norton NB. Clinical features of patients with recurrent invasive Streptococcus pneumoniae disease. Am J Med Sci. 2012;343:303–9.PubMedCrossRef
4.
Zurück zum Zitat Mason EO Jr, Wald ER, Tan TQ, Schutze GE, Bradley JS, Barson WJ, et al. Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J. 2007;26:480–4.PubMedCrossRef Mason EO Jr, Wald ER, Tan TQ, Schutze GE, Bradley JS, Barson WJ, et al. Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J. 2007;26:480–4.PubMedCrossRef
5.
Zurück zum Zitat Matsubara K, Fukaya T, Ubukata K, Chen M, Nigami H, Harigaya H, et al. Recurrence of occult pneumococcal bacteremia by an identical strain in an apparently healthy child. J Infect. 2007;54:e87–90.PubMedCrossRef Matsubara K, Fukaya T, Ubukata K, Chen M, Nigami H, Harigaya H, et al. Recurrence of occult pneumococcal bacteremia by an identical strain in an apparently healthy child. J Infect. 2007;54:e87–90.PubMedCrossRef
6.
Zurück zum Zitat Rodríguez-Avial I, Ramos B, Ríos E, Cercenado E, Ordobás M, Sanz JC, on behalf of the Madrid Streptococcus pneumoniae Microbiological Group (MSPSG). Clonal spread of levofloxacin-resistant Streptococcus pneumoniae invasive isolates in Madrid, Spain (2007–2009). Antimicrob Agents Chemother. 2011;55:2469–71.PubMedCentralPubMedCrossRef Rodríguez-Avial I, Ramos B, Ríos E, Cercenado E, Ordobás M, Sanz JC, on behalf of the Madrid Streptococcus pneumoniae Microbiological Group (MSPSG). Clonal spread of levofloxacin-resistant Streptococcus pneumoniae invasive isolates in Madrid, Spain (2007–2009). Antimicrob Agents Chemother. 2011;55:2469–71.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Sanz JC, Cercenado E, Marín M, Ramos B, Ardanuy C, Rodríguez-Avial I, et al. Multidrug-resistant pneumococci (serotype 8) causing invasive disease in HIV + patients. Clin Microbiol Infect. 2011;17:1094–8.PubMedCrossRef Sanz JC, Cercenado E, Marín M, Ramos B, Ardanuy C, Rodríguez-Avial I, et al. Multidrug-resistant pneumococci (serotype 8) causing invasive disease in HIV + patients. Clin Microbiol Infect. 2011;17:1094–8.PubMedCrossRef
8.
Zurück zum Zitat CLSI performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. CLSI document M100-S18. Wayne: Clinical and Laboratory Standards Institute; 2008. CLSI performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. CLSI document M100-S18. Wayne: Clinical and Laboratory Standards Institute; 2008.
9.
Zurück zum Zitat Clinical and Laboratory Standard Institute (CLSI). Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. CLSI document M100-S17. Wayne: Clinical and Laboratory Standards Institute; 2007. Clinical and Laboratory Standard Institute (CLSI). Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. CLSI document M100-S17. Wayne: Clinical and Laboratory Standards Institute; 2007.
10.
Zurück zum Zitat McEllistrem MC, Stout JE, Harrison IH. Simplified protocol for pulsed-field gel electrophoresis analysis of Streptococcus pneumoniae. J Clin Microbiol. 2000;38:351–3.PubMedCentralPubMed McEllistrem MC, Stout JE, Harrison IH. Simplified protocol for pulsed-field gel electrophoresis analysis of Streptococcus pneumoniae. J Clin Microbiol. 2000;38:351–3.PubMedCentralPubMed
11.
Zurück zum Zitat Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strains typing. J Clin Microbiol. 1995;33:2233–9.PubMedCentralPubMed Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strains typing. J Clin Microbiol. 1995;33:2233–9.PubMedCentralPubMed
12.
Zurück zum Zitat King MD, Whitney CG, Parekh F, Farley MM. Active bacterial core surveillance team/emerging infections program network. Recurrent invasive pneumococcal disease: a population-based assessment. Clin Infect Dis. 2003;37:1029–36.PubMedCrossRef King MD, Whitney CG, Parekh F, Farley MM. Active bacterial core surveillance team/emerging infections program network. Recurrent invasive pneumococcal disease: a population-based assessment. Clin Infect Dis. 2003;37:1029–36.PubMedCrossRef
13.
Zurück zum Zitat Einarsdóttir HM, Erlendsdóttir H, Kristinsson KG, Gottfredsson M. Nationwide study of recurrent invasive pneumococcal infections in a population with a low prevalence of human immunodeficiency virus infection. Clin Microbiol Infect. 2005;11:744–9.PubMedCrossRef Einarsdóttir HM, Erlendsdóttir H, Kristinsson KG, Gottfredsson M. Nationwide study of recurrent invasive pneumococcal infections in a population with a low prevalence of human immunodeficiency virus infection. Clin Microbiol Infect. 2005;11:744–9.PubMedCrossRef
14.
Zurück zum Zitat Antonio M, Oluwalana C, Secka O, Corrah T, Howie S, Adegbola RA. Exogenous re-infection by a novel Streptococcus pneumoniae serotype 14 as a cause of recurrent meningitis in a child from the Gambia. Ann Clin Microbiol Antimicrob. 2009;8:3.PubMedCentralPubMedCrossRef Antonio M, Oluwalana C, Secka O, Corrah T, Howie S, Adegbola RA. Exogenous re-infection by a novel Streptococcus pneumoniae serotype 14 as a cause of recurrent meningitis in a child from the Gambia. Ann Clin Microbiol Antimicrob. 2009;8:3.PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4:144–54.PubMedCrossRef Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4:144–54.PubMedCrossRef
16.
Zurück zum Zitat Rodríguez-Créixems M, Muñoz P, Miranda E, Peláez T, Alonso R, Bouza E. Recurrent pneumococcal bacteremia. A warning of immunodeficiency. Arch Intern Med. 1996;156:1429–34.PubMedCrossRef Rodríguez-Créixems M, Muñoz P, Miranda E, Peláez T, Alonso R, Bouza E. Recurrent pneumococcal bacteremia. A warning of immunodeficiency. Arch Intern Med. 1996;156:1429–34.PubMedCrossRef
17.
Zurück zum Zitat Font B, Llimiñana C, Fontanals D, Pineda V, Segura F. Eleven-year study of recurrent pneumococcal bacteremia. Eur J Clin Microbiol Infect Dis. 2001;20:636–8.PubMed Font B, Llimiñana C, Fontanals D, Pineda V, Segura F. Eleven-year study of recurrent pneumococcal bacteremia. Eur J Clin Microbiol Infect Dis. 2001;20:636–8.PubMed
18.
Zurück zum Zitat van Driel JJ, Bekker V, Spanjaard L, van der Ende A, Kuijpers TW. Epidemiologic and microbiologic characteristics of recurrent bacterial and fungal meningitis in the Netherlands, 1988–2005. Clin Infect Dis. 2008;47:e42–51.PubMedCrossRef van Driel JJ, Bekker V, Spanjaard L, van der Ende A, Kuijpers TW. Epidemiologic and microbiologic characteristics of recurrent bacterial and fungal meningitis in the Netherlands, 1988–2005. Clin Infect Dis. 2008;47:e42–51.PubMedCrossRef
19.
Zurück zum Zitat Plevneshi A, Svoboda T, Armstrong I, Tyrrell GJ, Miranda A, Green K, et al. Toronto invasive bacterial diseases network. Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto. PLoS One. 2009;4:e7255.PubMedCentralPubMedCrossRef Plevneshi A, Svoboda T, Armstrong I, Tyrrell GJ, Miranda A, Green K, et al. Toronto invasive bacterial diseases network. Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto. PLoS One. 2009;4:e7255.PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Orlicek SL, Herrod HG, Leggiadro RJ, Luedtke G, English BK. Repeated invasive pneumococcal infections in young children without apparent underlying immunodeficiency. J Pediatr. 1997;130:284–8.PubMedCrossRef Orlicek SL, Herrod HG, Leggiadro RJ, Luedtke G, English BK. Repeated invasive pneumococcal infections in young children without apparent underlying immunodeficiency. J Pediatr. 1997;130:284–8.PubMedCrossRef
21.
Zurück zum Zitat Maugein J, Guillemot D, Dupont MJ, Fosse T, Laurans G, Roussel-Delvallez M, et al. Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties. Clin Microbiol Infect. 2003;9:280–8.PubMedCrossRef Maugein J, Guillemot D, Dupont MJ, Fosse T, Laurans G, Roussel-Delvallez M, et al. Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties. Clin Microbiol Infect. 2003;9:280–8.PubMedCrossRef
22.
Zurück zum Zitat Porat N, Arguedas A, Spratt BG, Trefler R, Brilla E, Loaiza C, et al. Emergence of penicillin-nonsusceptible Streptococcus pneumoniae clones expressing serotypes not present in the antipneumococcal conjugate vaccine. J Infect Dis. 2004;190:2154–61.PubMedCrossRef Porat N, Arguedas A, Spratt BG, Trefler R, Brilla E, Loaiza C, et al. Emergence of penicillin-nonsusceptible Streptococcus pneumoniae clones expressing serotypes not present in the antipneumococcal conjugate vaccine. J Infect Dis. 2004;190:2154–61.PubMedCrossRef
23.
Zurück zum Zitat Hunt Gerardo S, Citron DM, Goldstein EJ. PCR fingerprinting analysis for differentiation of Streptococcus pneumoniae reinfection versus relapse. Diagn Microbiol Infect Dis. 2000;36:275–8.PubMedCrossRef Hunt Gerardo S, Citron DM, Goldstein EJ. PCR fingerprinting analysis for differentiation of Streptococcus pneumoniae reinfection versus relapse. Diagn Microbiol Infect Dis. 2000;36:275–8.PubMedCrossRef
24.
Zurück zum Zitat Gutierrez Rodríguez MA, Varela González A, Ordobás Gavín MA, Martín Martínez F, García Marína N, Ramos Blázquez B, et al. Invasive pneumococcal disease: association between serotype, clinical presentation and lethality. Vaccine. 2011;29:5740–6.CrossRef Gutierrez Rodríguez MA, Varela González A, Ordobás Gavín MA, Martín Martínez F, García Marína N, Ramos Blázquez B, et al. Invasive pneumococcal disease: association between serotype, clinical presentation and lethality. Vaccine. 2011;29:5740–6.CrossRef
25.
Zurück zum Zitat Ardanuy C, Rolo D, Fenoll A, Tarrago D, Calatayud L, Liñares J. Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J Antimicrob Chemother. 2009;64:507–10.PubMedCrossRef Ardanuy C, Rolo D, Fenoll A, Tarrago D, Calatayud L, Liñares J. Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J Antimicrob Chemother. 2009;64:507–10.PubMedCrossRef
26.
Zurück zum Zitat Ritchie ND, Mitchell TJ, Evans TJ. What is different about serotype 1 pneumococci? Future Microbiol. 2012;7:33–46.PubMedCrossRef Ritchie ND, Mitchell TJ, Evans TJ. What is different about serotype 1 pneumococci? Future Microbiol. 2012;7:33–46.PubMedCrossRef
27.
Zurück zum Zitat Munier AL, de Lastours V, Varon E, Donay JL, Porcher R, Molina JM. Invasive pneumococcal disease in HIV-infected adults in France from 2000 to 2011: antimicrobial susceptibility and implication of serotypes for vaccination. Infection. 2013;41:663–8.PubMedCrossRef Munier AL, de Lastours V, Varon E, Donay JL, Porcher R, Molina JM. Invasive pneumococcal disease in HIV-infected adults in France from 2000 to 2011: antimicrobial susceptibility and implication of serotypes for vaccination. Infection. 2013;41:663–8.PubMedCrossRef
28.
Zurück zum Zitat Isea-Peña MC, Sanz-Moreno JC, Esteban J, Fernández-Roblas R, Fernández-Guerrero ML. Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae. Infection. 2013;41:935–9.PubMedCrossRef Isea-Peña MC, Sanz-Moreno JC, Esteban J, Fernández-Roblas R, Fernández-Guerrero ML. Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae. Infection. 2013;41:935–9.PubMedCrossRef
29.
Zurück zum Zitat Kang CI, Song JH, Kim SH, Chung DR, Peck KR, Thamlikitkul V, et al. Association of levofloxacin resistance with mortality in adult patients with invasive pneumococcal diseases: a post hoc analysis of a prospective cohort. Infection. 2013;41:151–7.PubMedCrossRef Kang CI, Song JH, Kim SH, Chung DR, Peck KR, Thamlikitkul V, et al. Association of levofloxacin resistance with mortality in adult patients with invasive pneumococcal diseases: a post hoc analysis of a prospective cohort. Infection. 2013;41:151–7.PubMedCrossRef
30.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC). Licensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years and older. MMWR. 2012;61:394–5. Centers for Disease Control and Prevention (CDC). Licensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years and older. MMWR. 2012;61:394–5.
31.
Zurück zum Zitat Vila-Corcoles A, Ochoa-Gondar O, Guzman-Avalos A, Gomez-Bertomeu F, Figuerola-Massana E, Raga-Luria X, et al. Incidence of pneumococcal infections among children under 15 years in southern Catalonia throughout the heptavalent conjugate vaccine era, 2002–2009. Infection. 2013;41:439–46.PubMedCrossRef Vila-Corcoles A, Ochoa-Gondar O, Guzman-Avalos A, Gomez-Bertomeu F, Figuerola-Massana E, Raga-Luria X, et al. Incidence of pneumococcal infections among children under 15 years in southern Catalonia throughout the heptavalent conjugate vaccine era, 2002–2009. Infection. 2013;41:439–46.PubMedCrossRef
32.
Zurück zum Zitat Schutze GE, Tucker NC, Mason EO Jr. Failure of the conjugate pneumococcal vaccine to prevent recurrent bacteremia in a child with human immunodeficiency virus disease. Pediatr Infect Dis J. 2001;20:1009–10.PubMedCrossRef Schutze GE, Tucker NC, Mason EO Jr. Failure of the conjugate pneumococcal vaccine to prevent recurrent bacteremia in a child with human immunodeficiency virus disease. Pediatr Infect Dis J. 2001;20:1009–10.PubMedCrossRef
33.
Zurück zum Zitat Nunes MC, Madhi SA. Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals. Hum Vaccin Immunother. 2012;8:1–13.CrossRef Nunes MC, Madhi SA. Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals. Hum Vaccin Immunother. 2012;8:1–13.CrossRef
34.
Zurück zum Zitat American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23). Pediatrics. 2010;126:186–90.CrossRef American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23). Pediatrics. 2010;126:186–90.CrossRef
35.
Zurück zum Zitat Picazo JJ, González-Romo F, García Rojas A, Pérez-Trallero E, Gil Gregorio P, de la Cámara R, et al. Consenso sobre la vacunación anti-neumocócica en el adulto con patología de base. Rev Esp Quimioter. 2013;26:232–52.PubMed Picazo JJ, González-Romo F, García Rojas A, Pérez-Trallero E, Gil Gregorio P, de la Cámara R, et al. Consenso sobre la vacunación anti-neumocócica en el adulto con patología de base. Rev Esp Quimioter. 2013;26:232–52.PubMed
Metadaten
Titel
Recurrent pneumococcal invasive disease in the Region of Madrid during a five-year period
verfasst von
J. C. Sanz
I. Rodríguez-Avial
E. Ríos
B. Ramos
E. Cercenado
Publikationsdatum
01.06.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 3/2014
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-013-0571-3

Weitere Artikel der Ausgabe 3/2014

Infection 3/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.